Pfizer's Profit Rises 10% Amid Lower Costs

in the world by sales, has diversified and grown bigger through mega-mergers, including the $68 billion purchase of Wyeth in 2009. But low productivity in its research and development efforts?coupled with patent expirations for top-selling drugs?has put...